Two Sigma Investments, LP Athenex, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $0.21 $5,376 - $9,408	44,800 New	44,800 $6,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $969,671 - $1.34 Million	-261,367 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $682,877 - $2.47 Million	-167,372 Reduced 39.04%	261,367 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $4.23 Million - $5.35 Million	382,151 Added 820.28%	428,739 $4.74 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $477,992 - $677,855	46,588 New	46,588 $564,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $2.18 Million - $4.21 Million	-306,075 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $1.55 Million - $4.3 Million	271,542 Added 786.33%	306,075 $2.37 Million
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $1.35 Million - $2.5 Million	-140,797 Reduced 80.3%	34,533 $527,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $2.13 Million - $3.68 Million	175,330 New	175,330 $2.13 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.